Bone mineral density improvement in spondyloarthropathy after treatment with etanercept.
Marzo-Ortega
H
H
McGonagle
D
D
Haugeberg
G
G
Green
M J
MJ
Stewart
S P
SP
Emery
P
P
D000328:Adult; D015519:Bone Density / Q000187:drug effects*; D000068800:Etanercept; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*; D025242:Spondylarthropathies / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept